NEWAMSTERDAM PHARMA COMPANY (NAMSW) Institutional Shareholders

NEWAMSTERDAM PHARMA COMPANY (NAMSW) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026. The institutional investors covered on this page collectively reported approximately $4.09B in NAMSW holdings during the latest filing period.

Frazier Life Sciences Management, L.P. is currently the largest disclosed institutional shareholder of NAMSW tracked by InsiderSet, reporting ownership valued at approximately $613.03M in its June 30, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $207.84M, representing an estimated loss of -66.10% since the filing period.

The top 10 institutional shareholders tracked on this page collectively account for approximately 64% of the total disclosed NAMSW value among the investors covered in this analysis. Major shareholders include Frazier Life Sciences Management, L.P., Capital World Investors, Fmr Llc, and several other long-term asset managers with concentrated positions in NEWAMSTERDAM PHARMA COMPANY (NAMSW).

This page ranks the largest institutional NAMSW shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.

Institutional Holders

190

Total Reported Value

$4.09B

Largest Holder

Frazier Life Sciences Management, L.P.

Largest Position

$613.03M

Insider Transactions (90d)

0

Latest Filing Quarter

Q2 2026

New Institutional Positions

63

Funds Exiting Positions

0

NameInvestor/ManagerPortfolio %QuantityReported BalanceCurrent Estimated ValueGain/loss Since FilingEstimated Portfolio Performance
Frazier Life Sciences Management, L.P.13.35%18,088,902$613,032,889$207,841,484-$405,191,405-66.10%
Capital World Investors0.05%12,230,557$414,493,577$140,529,100-$273,964,477-66.10%
Fmr Llc0.02%10,339,663$350,411,179$118,802,728-$231,608,451-66.10%
Ra Capital Management, L.P.2.81%9,550,191$323,655,973$109,731,695-$213,924,278-66.10%
Fcpm Iii Services B.V.38.34%8,490,353$287,738,063$97,554,156-$190,183,907-66.10%
Deerfield Management Company, L.P.1.51%4,264,789$144,533,699$49,002,426-$95,531,273-66.10%
Viking Global InvestorsOle Andreas Halvorsen0.41%4,203,567$142,458,886$48,298,985-$94,159,901-66.10%
Bain Capital Life Sciences Investors, Llc7.67%3,806,566$129,004,522$43,737,443-$85,267,079-66.10%
Maverick Capital Ltd1.00%3,267,802$110,745,810$37,547,045-$73,198,765-66.10%
Duquesne Family Office LlcStanley Druckenmiller2.39%3,070,146$104,047,000$35,275,978-$68,771,022-66.10%
Medicxi Ventures Management (Jersey) Ltd42.19%2,208,639$74,850,776$25,377,262-$49,473,514-66.10%
Janus Henderson Group Plc0.04%2,258,984$72,253,603$25,955,726-$46,297,877-64.08%
Jennison Associates Llc0.04%2,102,286$71,246,471$24,155,266-$47,091,205-66.10%
Orbis Allan Gray Ltd0.20%1,747,627$59,227,079$20,080,234-$39,146,845-66.10%
Polar Capital Holdings Plc0.17%1,724,518$58,443,915$19,814,712-$38,629,203-66.10%
Capital International Investors0.01%1,723,495$58,409,246$19,802,958-$38,606,288-66.10%
Goldman Sachs Group Inc0.01%1,544,911$52,357,034$17,751,027-$34,606,007-66.10%
Westfield Capital Management Co Lp0.17%1,536,472$52,071,036$17,654,063-$34,416,973-66.10%
Castle Hook Partners Lp0.50%1,371,005$46,463,359$15,752,847-$30,710,512-66.10%
Ameriprise Financial Inc0.01%1,253,549$42,482,886$14,403,278-$28,079,608-66.10%
Alliancebernstein L.P.0.01%1,259,940$40,330,679$14,476,711-$25,853,968-64.10%
Price T Rowe Associates Inc0.00%1,167,357$39,562,000$13,412,932-$26,149,068-66.10%
Jpmorgan Chase & Co0.00%1,132,955$38,373,185$13,017,653-$25,355,532-66.08%
Aberdeen Group Plc0.05%1,102,785$37,373,384$12,671,000-$24,702,384-66.10%
Blackrock, Inc.0.00%1,063,750$36,050,487$12,222,488-$23,828,000-66.10%
Timessquare Capital Management, Llc0.40%796,162$26,981,930$9,147,901-$17,834,029-66.10%
Bnp Paribas Asset Management Holding S.A.0.03%781,140$26,472,835$8,975,299-$17,497,536-66.10%
Susquehanna International Group, Llp0.02%754,327$25,564,142$8,667,217-$16,896,925-66.10%
Woodline Partners Lp0.08%752,489$25,501,852$8,646,099-$16,855,753-66.10%
Bank Of America Corp0.00%735,483$24,925,518$8,450,700-$16,474,818-66.10%
Nwi Management Lp1.52%702,000$23,791,000$8,065,980-$15,725,020-66.10%
American Century Companies Inc0.01%684,813$23,208,343$7,868,501-$15,339,842-66.10%
Citadel Advisors Llc0.01%645,805$21,886,331$7,420,299-$14,466,032-66.10%
Rock Springs Capital Management Lp0.96%582,744$19,749,194$6,695,729-$13,053,465-66.10%
First Turn Management, Llc2.11%582,497$19,740,823$6,692,891-$13,047,932-66.10%
Morgan Stanley0.00%575,825$19,514,724$6,616,229-$12,898,495-66.10%
Adage Capital Partners Gp, L.L.C.0.03%550,000$18,639,500$6,319,500-$12,320,000-66.10%
Artia Global Partners Lp3.25%503,936$17,078,391$5,790,225-$11,288,166-66.10%
Millennium Management Llc0.01%501,614$16,999,698$5,763,545-$11,236,153-66.10%
Cormorant Asset Management, Lp0.87%500,000$16,945,000$5,745,000-$11,200,000-66.10%
Jane Street Group, Llc0.01%474,236$16,071,858$5,448,972-$10,622,886-66.10%
Kennedy Capital Management Llc0.25%421,374$14,280,365$4,841,587-$9,438,778-66.10%
Bank Of New York Mellon Corp0.00%353,298$11,973,270$4,059,394-$7,913,876-66.10%
Hrt Financial Lp0.02%349,843$11,856,000$4,019,696-$7,836,304-66.10%
Ubs Group Ag0.00%344,065$11,660,363$3,953,307-$7,707,056-66.10%
Slate Path Capital Lp0.15%319,000$10,810,910$3,665,310-$7,145,600-66.10%
Lord, Abbett & Co. Llc0.03%306,560$10,389,000$3,522,374-$6,866,626-66.10%
Exoduspoint Capital Management, Lp0.10%304,334$10,313,879$3,496,798-$6,817,081-66.10%
Eversept Partners, Lp0.51%275,471$9,335,712$3,165,162-$6,170,550-66.10%
Affinity Asset Advisors, Llc0.46%275,000$9,319,750$3,159,750-$6,160,000-66.10%
Showing 50 of 190

Frequently asked questions about NAMSW

  • Who owns the most NAMSW stock?

    The largest holders of NAMSW are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for NEWAMSTERDAM PHARMA COMPANY (NAMSW).

  • Is NAMSW widely held by superinvestors?

    Many widely followed stocks like NAMSW appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly NAMSW is represented among the institutional managers we track.

  • What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?

    Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.